Dudediligence.

Incannex Healthcare Inc

IXHLNASDAQ · Pharmaceutical Preparations
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

12.5M

on 2026-09-24, from 431K on 2024-03-31 10-K ↗

Earlier counts are adjusted for the 1-for-30 reverse split; each bar's tip shows the count as filed.

a raise that quarter, at its price

Newest

$150.0M

S-3 of 2024-11-06. 1 prospectus supplement filed under it since. S-3 ↗

$100.0M

Agreement of 2025-05-27. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

No warrant count read from a 10-Q or 10-K.

Cash

21 quarters

$67.7M on 2026-06-30 ÷ $3.2M a quarter of operating cash used, the average of four quarters. 10-K ↗

Raised
DateWhatSharesPriceGrossFiling
2026-03-12Public offering incl. 0.00M pre-funded, with warrants at $6.502,000,000$5.00$10.0M424B5 ↗
2025-03-07Private placement incl. 1.89M pre-funded3,774,090$1.08not stated8-K ↗

Also on file: a 1-for-2 reverse split, 2025-05-27 8-K ↗